TMC is a global clinical research organisation dedicated to supporting the progression of life-saving treatment solutions for diseases that are often neglected.

We’re a specialised and experienced full-service CRO providing world-class support to pharma/biotech companies. To maximise success, we offer our clients a broad range of services with a focused and tailored approach for all their drug development requirements.

global partner

A Message From Our CEO

Simon Estcourt

With the most recent appointment of our CFO, we now have a full complement of C-Suite Directors that has strengthened our leadership team and, with our combined experience and expertise, aptly positions us to move into the Company’s next phase of growth. The role of specialist CRO’s, like TMC, is more crucial than ever and the work we do is of the utmost importance as we strive to develop innovative treatments that will improve the quality of life for individuals worldwide.

TMC directors

Our Expertise

Our development support activities span the early pre-clinical phase right through to post-marketing. We provide all the functions of a fully resourced pharmaceutical company, providing ‘bolt-on’ services that complement a client’s in-house resource, enabling them to access all the development capability appropriate for each stage of their project.


We only employ knowledgeable and trusted Associates who have worked in the pharma industry for at least 15 years. These experts can draw on their extensive experience to guide programmes and strategies — providing flexible, integrated and cost-effective solutions to meet our clients’ needs.


We specialise in orphan, rare and oncology diseases. Rare diseases affect 1 in 10 people, meaning more than 350 million people worldwide*. These people are often overlooked as there are significant challenges in the design and execution of clinical trials therapeutics. That’s why it’s our mission, indeed our passion, to offer drug development support in these disease areas.



No two drug development programmes are the same — just as no two patients are the same. We help our clients understand the patient journey, facilitating their drug development pathway to bring treatments to market quickly and efficiently.

watch our latest recorded


Exploring the Differences in Medical Services for Rare Diseases

Milestones in Numbers

Championing the patients living with life-limiting orphan and rare diseases

0 years
since TMC was founded
associates worldwide
paediatric investigation plans (PIP)
orphan drug designation (ODD) applications